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Assessing Patient-Provider Collaboration in  Type 2 Diabetics (in Jamaica) 
and Effects on Glycemic Control
BACKGROUND
• Type 2 diabetes mellitus is a growing health problem worldwide.
•  Primary pathophysiology of this disease stems from impaired glucose 
uptake via insulin resistance that results in symptomology ranging from 
polydypsia and polyphagia to potentially life threatening hyperglycemic 
episodes.
•  Major effects on health and healthcare costs are from microvascular 
complications of diabetic nephropathy, neuropathy and retinopathy, 
which can lead to end-stage renal disease, extremity amputation, and 
blindness, respectively.
•  Timely screening and outpatient referrals, as well as good glycemic 
control, have been shown to slow the progression of complications.
•  Recent trend in the United States for management of chronic conditions 
(such as type 2 diabetes) focuses on patient-centeredness which 
advocates for increased collaboration between caregivers such as nurses 
and physicians with patients to produce a management plan that is 
feasible for the patient.
•  In Jamaica, the incidence of type 2 diabetes has been steadily increasing 
since 1960, with current estimates of a diabetic population exceeding 
300,000. Some research suggests poor glycemic control in sample 
populations and high rates of complications such as retinopathy.
•  As a counter measure, organizations such as the Diabetes Association of 
Jamaica have implemented educational workshops to make the general 
population more aware of this disease and its complications.
•  Beyond the education of the public and management by physicians, it 
would be interesting to assess the perception of patient-centeredness in 
Jamaicans suffering from type 2 diabetes and determine if there any 
implications for management of their condition.
PURPOSE
• To compare Patient Assessment of Care of Chronic Conditions (PACIC) 
scores to hemoglobin A1C values in subjects with type 2 diabetes and to 
determine the correlation between patient-physician collaboration and 
glycemic control.
BACKGROUND AND PURPOSE METHODS
STUDY POPULATION AND DATA
• Study population was predominantly female (78.9%; 15 women/4 men), 
had an age range of 33-78 years (mean 55), years diagnosed with 
diabetes 0.03 – 32 years (mean 14), Hemoglobin A1c values from 5.40% 
– 15.5% (mean 10.8%), and with a majority (42.1%; 8 participants) 
receiving a combination of insulin and an oral hypoglycemic agent as a 
treatment modality. (See Figure 1)
DATA ANALYSIS
• Overall, PACIC scores ranged from 1.85 – 4.80 (mean 3.15).
• Main variables of PACIC scores and HbA1c were subject to analysis via 
the Pearson correlation, but no statistically significant correlation was 
found (r=.184).
• Additionally, HbA1c did not correlate significantly with the other 
variables of patient age (-.408), and years diagnosed with diabetes 
   (-.244).
   These data were also re-computed using non-parametric correlation
  coefficients to take small sample sizes into account.  However, no
  statistically significant correlations were found.
• Likely the study is underpowered to find statistically significant 
correlations between PACIC scores and other key study variables.
  (See Figure 2 below)
RESULTS
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STUDY DESIGN AND RECRUITMENT
•  A cross-sectional observation study measuring patient-to-provider 
collaboration in type 2 diabetics in a sample population in Jamaica.
•  Patients recruited from the diabetes clinic at the University of the West 
Indies hospital in Mona, Jamaica on August 15, 2011 and August 22, 
2011.
•  40 subjects were screened and 19 were ultimately enrolled after meeting 
the following inclusion criteria:
 1. Males or females 18 years old and above diagnosed with type 2  
       diabetes as confirmed by laboratory testing by either one of the  
       following: a fasting plasma glucose > 126 mg/dL (7 mmol/L) (no 
       caloric intake for > 8 hours) with symptoms (polyuria, polydipsia, 
       weight loss) or with random plasma glucose > 200 mg/dL 
       (11.1 mmol/L), or a HbA1c ≥ 6.5%
 2. Ability to provide written informed consent
 3. Ability to complete PACIC questionnaire (subjects had to be able to 
       read and comprehend English)
•  Subjects were excluded based on the following criteria:
 1. Males and females without a documented history of type 2 diabetes  
       (as described in inclusion criteria)
 2. Pregnant women
 3. Patients without hemoglobin A1c testing within 3 months of 
       participation
VARIABLES
•  The Patient Assessment of Care of Chronic Conditions (PACIC) 
questionnaire was our measure of patient-to-physician collaboration. 
The PACIC is a validated instrument that was been used to assess the 
level of collaboration patients with chronic disease feel they have with 
their healthcare providers.
•  The PACIC measures five subjective categories: 1) Patient activation; 2) 
Delivery system design and decision support; 3) Goal setting; 4) 
Problem solving/contextual counseling; and 5) Follow-up/coordination. 
The overall PACIC score measures patient-to-physician collaboration 
with a range from a low of 1.0 to a high of 5.0.
•  Hemoglobin A1c (HbA1c%), which measures the amount of 
glycosolated hemoglobin (as a percentage) for the past 3 months, was 
our measure of glycemic control.
•  Additional study data for both characterization of the study population 
and analysis of potential confounders were: age, sex, years diagnosed 
with diabetes, and current diabetic therapy (i.e., no therapy, lifestyle 
modification, insulin alone, oral hypoglycemic agents or a combination 
of insulin/oral hypoglycemic agents).
STUDY PROCEDURES
•  Subjects were consented, assigned a study number, and self-
administered the PACIC in a private exam room.
•  The investigator (PD) collected additional study data as described above.
• Implementation, data collection and administration of the questionnaire 
was straightforward and did not interfere or prolong patient 
appointments. Thus, testing patient-to-provider collaboration could 
potentially be a component of visits for patients with chronic illness. 
However, further studies are needed to evaluate efficiency and cost-
effectiveness.
• Recruitment was suboptimal with the limiting factor being that most 
subjects could not afford Hemoglobin a1c testing as part of their diabetic 
management.
• No statistically significant associations between our main variables of 
patient and provider collaboration (PACIC score) and glycemic control 
(HbA1c) were found. Analysis of potential confounders also failed to 
illicit any correlations.
• The major limitation in our study stems from our small sample size. An 
important next step would be to repeat this study with a larger sample 
and currently, the process of gathering additional subjects is underway.
• In summary, it is unclear what impact patient-to-physician collaboration 
will have on glycemic control in type 2 diabetics. However, if results are 
favorable, as suggested by past research, and demonstrate a clinical 
benefit, the PACIC could potentially be an additional tool for physicians 
treating type 2 diabetes in controlling this disease and limiting 
complications.
CONCLUSIONS
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(Figure 1) STUDY POPULATION & VARIABLES    
  Total (n) Percent (%)
Gender                   Male
                                   Female
                                       
4 21.1
15 78.9
   
Current Therapy:    No therapy 0 0
                                           Lifestyle Modification 0 0
                                Insulin 7 36.8
                                Oral hypoglycemic agent 4 21.1
                                           Insulin + Oral hypoglycemic 8 42.1
     
  Range Mean
                                   Years since diagnosis 0.03-32 14
                                   Subject age   33-78 55
                                   HbA1c values 5.4-15.5 10.8
                                   PACIC scores 1.85-4.80 3.15
(Figure 2) CORRELATIONS      
  HbA1c 
Value
PACIC 
Score
Years 
Since 
Diagnosis
HbA1c Value         Pearson Correlation
                               Sig (2-tailed)
                               N
1.0 0.184 -0.244
  0.465 0.314
19.0 18 19
PACIC Score         Pearson Correlation
                               Sig (2-tailed)
                               N
0.184 1 0.046
0.465   0.856
18.0 18 18
Years Since           Pearson Correlation
Diagnosis              Sig (2-tailed)
                               N
-0.244 0.046 1
0.314 0.856  
19.0 18 19
Patient Age           Pearson Correlation
                               Sig (2-tailed)
                               N
-0.408 -0.048 0.257
0.083 0.849 0.288
19.0 18 19
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